Medicina
Facultad
NewYork–Presbyterian Hospital
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de NewYork–Presbyterian Hospital (29)
2023
-
Correction: Epidemiology and outcomes of early-onset AKI in COVID-19-related ARDS in comparison with non-COVID-19-related ARDS: insights from two prospective global cohort studies (Critical Care, (2023), 27, 1, (3), 10.1186/s13054-022-04294-5)
Critical Care
-
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
European Urology
-
Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022
European Journal of Cancer
2022
-
Association of chest compression pause duration prior to E-CPR cannulation with cardiac arrest survival outcomes
Resuscitation, Vol. 177, pp. 85-92
-
Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis
Critical Care, Vol. 26, Núm. 1
-
Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation
The oncologist, Vol. 27, Núm. 7, pp. e561-e570
-
Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial
Nature communications, Vol. 13, Núm. 1, pp. 1878
2021
-
An appraisal of respiratory system compliance in mechanically ventilated covid-19 patients
Critical Care, Vol. 25, Núm. 1
-
Assessment of 28-Day In-Hospital Mortality in Mechanically Ventilated Patients with Coronavirus Disease 2019: An International Cohort Study
Critical Care Explorations, Vol. 3, Núm. 11, pp. E0567
-
Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS
Leukemia, Vol. 35, Núm. 3, pp. 835-849
2020
-
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
Nature Medicine, Vol. 26, Núm. 6, pp. 878-885
-
Correction to: Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism (Internal and Emergency Medicine, (2019), 14, 7, (1101-1112), 10.1007/s11739-019-02077-5)
Internal and Emergency Medicine
-
Thirty-day outcomes in patients with proximal deep vein thrombosis who discontinued anticoagulant therapy prematurely
Thrombosis Research, Vol. 189, pp. 61-68
2019
-
Correction to: Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism (Internal and Emergency Medicine, (2019), 14, 7, (1101-1112), 10.1007/s11739-019-02077-5)
Internal and Emergency Medicine
-
Effects of ABO matching of platelet transfusions in critically III children
Pediatric Critical Care Medicine, Vol. 20, Núm. 2, pp. E61-E69
-
International Study of the Epidemiology of Platelet Transfusions in Critically Ill Children with an Underlying Oncologic Diagnosis
Pediatric Critical Care Medicine, Vol. 20, Núm. 7, pp. e342-e351
-
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial
The Lancet Oncology, Vol. 20, Núm. 3, pp. 420-435
-
Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism
Internal and Emergency Medicine
2018
-
Platelet Transfusion Practices in Critically Ill Children
Critical Care Medicine, Vol. 46, Núm. 8, pp. 1309-1317